Call us: 1.877.283.7882 | Monday–Friday: 8:00 AM–4:30 PM ET

Private MD News

Home | News | Infectious Diseases

Hepatitis C therapy shows promise

Category: Infectious Diseases

Hepatitis C therapy shows promise

Pharmaceutical company Gilead's stock price rose to $72.73 per share, the highest it's been in nearly 20 years, after its hepatitis C treatment successfully treated patients involved in an experimental trial, reported Bloomberg.

Gilead is one of several companies racing to find a treatment for hepatitis C that works quickly and without side effects. Rival manufacturers Achillion Pharmaceuticals and Vertex Pharmaceuticals showed a decline in the marketplace - 20 percent and 5.1 percent, respectively - after the news of Gilead's success broke, according to Bloomberg.

"In 2013, given that Gilead's regimen has the best overall profile (efficacy, safety, convenience), we anticipate a significant amount of warehousing," wrote Ravi Mehrotra, an analyst for Credit Suisse, in a research note.

Runner up
Another pharmaceutical company, Abbott, showed signs of success in developing a treatment for the virus. By combining three drugs along with a booster known as ritonavir, 87 percent of the subjects involved in its 12-week trial were cleared of the disease, and another combination of its drugs, which involved the hepatitis C medication ribavirin, cured 97 percent of the patients. Gilead's treatment regimen has the advantage though because it uses fewer pills, reported Bloomberg.

Hepatitis C
Hepatitis C, which can be detected with blood testing, is usually contracted through contact with blood. According to the National Institutes of Health (NIH), some symptoms include abdominal pain, dark urine, fever, nausea and a loss of appetite.

Traditional treatment for the disease seeks to eliminate the virus from the blood in order to decrease the chance of developing liver cancer and cirrhosis of the liver.

Some prevention methods that the NIH recommends include not taking intravenous drugs, and for healthcare workers to always be cautious when handling blood and other bodily fluids. Sexual partners should also be screened for the disease, even though the likelihood of transmitting hepatitis C via intercourse is low.


Related Articles from Private MD:

Share on Facebook

Subscribe to Private MD Health News RSS Feed: Subscribe

News Categories:

Advanced Lipid Treatment I   Allergy Testing   Anemia and RBC disorders   Autoimmune Diseases   Bariatric Lab Testing   Blood and Blood Diseases   Breast   Cancer Detection and Tumor Markers   Celiac Disease Testing   Chlamydia   Coagulation and blood clotting disorders   Colon   Diabetes   DNA, Paternity and Genetic testing   Drug Screening   Environmental Toxin Testing   Female Specific Tests   Gastrointestinal Diseases   General Health   General Wellness   Heart Health and Cholesterol   Herpes   HIV   HIV monitoring/Treatment/Testing/Post Diagnos   Hormones and Metabolism   Infectious Diseases   Infertility Testing-Male   Infertitlity Hormone Testing   Kidney Diseases   Leukemia and WBC disorders   Liver   Liver Diseases   Lyme Disease   Male Specific Tests   Menopause/Peri-Menopausal Diagnosis   Musculoskeletal Diseases   Organ Specific Testing   Ovarian   Prostate   Sexually Transmitted Diseases   Thyroid Diseases   Transgender Hormone Testing-female to male   Transgender Hormone Testing-Male to Female   Vitamin D Deficiency-Diagnosis and Treatment   

Visit the Health News Archive: Click Here

Questions about online blood testing or how to order a lab test? Click here to get started or call us toll-free at 1.877.283.7882. Our professionals are ready to assist you.

Back to top